Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) Sets New 12-Month High – Here’s Why

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY)’s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as $11.28 and last traded at $11.25, with a volume of 115656 shares trading hands. The stock had previously closed at $10.93.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Barclays raised Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München to a “strong-buy” rating in a research note on Tuesday, January 28th. UBS Group cut shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a “strong-buy” rating to a “hold” rating in a research report on Thursday, December 19th. Finally, Berenberg Bank lowered shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 25th.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Price Performance

The stock has a market cap of $75.24 billion, a PE ratio of 7.31, a P/E/G ratio of 1.73 and a beta of 1.03. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.20. The company has a fifty day moving average of $10.55 and a 200-day moving average of $10.47.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Company Profile

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.